Can tracking heart-kidney-metabolic syndrome in india reveal its hidden patterns?

NCT ID NCT07718789

Not yet recruiting Knowledge-focused Sponsor: Centre for Chronic Disease Control, India Source: ClinicalTrials.gov ↗

First seen Jul 22, 2026 · Last updated Jul 23, 2026 · Updated 1 time

Summary

This observational registry study follows 2,250 adults with cardiovascular-kidney-metabolic syndrome (CKMS) at five hospitals in India. Researchers aim to understand how the condition progresses over 12 months, how it affects quality of life, and what treatments doctors prescribe. Participants provide health information, blood and urine samples, and undergo heart tests, while continuing their usual medical care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this registry could reveal how CKMS progresses in Indian adults and guide better prevention and treatment strategies.
What could go wrong: As an observational registry, it cannot test treatments or prove cause and effect. Results may not apply to other populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIOVASCULAR KIDNEY METABOLIC SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cardiovascular disorder cardiovascular-kidney-metabolic syndrome chronic renal failure syndrome hypertensive disorder hypertriglyceridemia Obesity type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CARDIOVASCULAR KIDNEY METABOLIC SYNDROME

More trials for these conditions

Other studies related to the condition(s) this trial covers.